Carregant...
Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond
Heart failure remains a major concern across the globe as life expectancies and delivery of health care continue to improve. There has been a dearth of new developments in heart failure therapies in the last decade until last year, with the release of the results from the PARADIGM-HF Trial heralding...
Guardat en:
| Publicat a: | Vasc Health Risk Manag |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4459540/ https://ncbi.nlm.nih.gov/pubmed/26082640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S55630 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|